IFNα Potentiates Immune-Checkpoint Blockade by Rewiring Metabolic Cross-talk
- PMID: 35791695
- DOI: 10.1158/2159-8290.CD-22-0472
IFNα Potentiates Immune-Checkpoint Blockade by Rewiring Metabolic Cross-talk
Abstract
In this issue, Hu and colleagues unveil that IFNα administration combined with anti-PD-1 therapy can potentiate murine and human CD8+ T-cell antitumor response in hepatocellular carcinoma, highlighting a novel therapeutic strategy for hepatocellular carcinoma. See related article by Hu et al., p. 1718 (6) .
©2022 American Association for Cancer Research.
Comment on
-
IFNα Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment.Cancer Discov. 2022 Jul 6;12(7):1718-1741. doi: 10.1158/2159-8290.CD-21-1022. Cancer Discov. 2022. PMID: 35412588
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
